ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients

Published:2019-01-10 Issue:6 Volume:60 Page:1420-1428
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mareckova Andrea¹,Malcikova Jitka¹,Tom Nikola²,Pal Karol²,Radova Lenka²,Salek David¹,Janikova Andrea¹,Moulis Mojmir³,Smardova Jana³,Kren Leos³,Mayer Jiri¹,Trbusek Martin¹

Affiliation:

1. Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;

2. Central European Institute of Technology (CEITEC), Center of Molecular Medicine, Masaryk University, Brno, Czech Republic;

3. Department of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic

Funder

Ministry of Health of the Czech Republic

Conceptual Development of Research Organization

TACR

MEYS

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1542144

Reference59 articles.

1. The p53 pathway: positive and negative feedback loops

2. p53 in health and disease

3. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis

4. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas

5. Mutation and genomic deletion status ofataxia telangiectasia mutated(ATM) andp53confer specific gene expression profiles in mantle cell lymphoma

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types;Clinical Cancer Research;2024-02-28

2. Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer;2024-02-08

3. Resistance to PRMT5-targeted therapy in mantle cell lymphoma;Blood Advances;2023-12-29

4. Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of <i>TP53</i> mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.;Haematologica;2023-11-30

5. Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents;Journal of Hematology & Oncology;2023-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3